AbbVie Inc.·4

Mar 3, 6:10 PM ET

Stewart Jeffrey Ryan 4

4 · AbbVie Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

AbbVie EVP Jeffrey Ryan Surrenders 23,812 Shares for Taxes

What Happened

  • Jeffrey Ryan, Executive Vice President and Chief Commercial Officer of AbbVie (ABBV), disposed of 23,812 shares on 2026-02-27 to satisfy a tax or exercise-related obligation. The shares were valued at $232.08 each, for a total of $5,526,289. This was a tax-withholding/net-share settlement event (routine), not an open-market sale meant as a directional trade.

Key Details

  • Transaction date and price: 2026-02-27 at $232.08 per share.
  • Shares disposed: 23,812; total value ≈ $5,526,289.
  • Shares owned after transaction: Not specified in this filing.
  • Footnote: The reporting person disclaims beneficial ownership of securities held by his spouse (F1).
  • Filing: Reported on 2026-03-03; appears to be filed in the normal timeframe.

Context

  • Code F indicates payment of an exercise price or tax liability (often a net-share settlement when options vest or RSUs vest). Such disposals are typically routine to cover withholding and do not necessarily signal the insider’s view on the company’s prospects.
  • For retail investors, purchases are generally more informative about insider sentiment; tax-withholding disposals are common and primarily administrative.

Insider Transaction Report

Form 4
Period: 2026-02-27
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2026-02-27$232.08/sh23,812$5,526,28983,171 total
Holdings
  • Common Stock, $0.01 par value

    [F1]
    (indirect: By Trust)
    1,338
Footnotes (1)
  • [F1]The reporting person disclaims beneficial ownership of all securities held by his spouse.
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Jeffrey R. Stewart|2026-03-03

Documents

1 file
  • 4
    form4-03032026_060311.xmlPrimary